MedPath
TGA Approval

SERENACE HALOPERIDOL 20mg tablet bottle. (111819)

111819

SERENACE HALOPERIDOL 20mg tablet bottle.

Proqualix Pty Ltd - in Administration

October 7, 2004

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

haloperidol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SERENACE HALOPERIDOL 20mg tablet bottle. (111819) - TGA 批准文号 | MedPath